Sunshine Heart Announces Company Name Change to CHF Solutions, Inc. and New NASDAQ Ticker Symbol to Reflect New Commercial Focus
(Thomson Reuters ONE) -
EDEN PRAIRIE, Minn., May 23, 2017 (GLOBE NEWSWIRE) -- Sunshine Heart,
Inc. (NASDAQ:SSH), an early-stage medical device company focused on the
commercialization of the Aquadex FlexFlow® System, today announced that on May
23, 2017, it is changing the name of the company to CHF Solutions, Inc.
"We are pleased to align our corporate name and identity with our new commercial
focus," said John Erb, Chairman of the Board and CEO of CHF Solutions. "CHF
Solutions has great brand recognition in the marketplace and more appropriately
reflects our business direction."
In conjunction with the name change, the company's ticker symbol listed on the
NASDAQ will change from SSH to CHFS, which is expected to be effective May
24,2017, and the CUSIP numbers for its common stock, Series E Convertible
Preferred Stock and the warrants issued in the Company's underwritten public
offering that closed on April 24, 2017 will change to 12542Q 102, 12542Q 201 and
12542Q 128, respectively. The company's official website will be changed
to www.chf-solutions.com, effective immediately.
About CHF Solutions
CHF Solutions, Inc. (Nasdaq:CHFS) is an early-stage medical device company
focused on commercializing the Aquadex FlexFlow® System. The company's
commercial product, the Aquadex system, is indicated for temporary (up to eight
hours) ultrafiltration treatment of patients with fluid overload who have failed
diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment
of patients with fluid overload who have failed diuretic therapy and require
hospitalization. The company's objective is to improve the quality of life for
patients with heart failure and related conditions. CHF Solutions is
a Delaware corporation headquartered in Minneapolis with wholly owned
subsidiaries in Australia and Ireland. The company has been listed on the NASDAQ
Capital Market since February 2012.
Forward-Looking Statements
Certain statements in this release are forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, including
statements regarding the company's ticker symbol and events or developments that
we expect or anticipate will occur in the future. Forward-looking statements
are predictions, projections and other statements about future events that are
based on current expectations and assumptions and, as a result, are subject to
risks and uncertainties. Many factors could cause actual future events to differ
materially from the forward-looking statements in this release, including,
without limitation, those risk associated with our ability to execute on our
recently announced strategic realignment, the possibility that we may be unable
to raise sufficient funds necessary for our anticipated operations, our post-
market clinical data collection activities, benefits of our products to
patients, our expectations with respect to product development and
commercialization efforts, our ability to increase market and physician
acceptance of our products, potentially competitive product offerings,
intellectual property protection, our ability to integrate acquired businesses,
our expectations regarding anticipated synergies with and benefits from acquired
businesses, and other risks and uncertainties described in our filings with the
SEC. Forward-looking statements speak only as of the date when made. CHF
Solutions does not assume any obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
For further information, please contact:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
T: +1-952-345-4205
Investor Relations
CHF Solutions, Inc.
ir(at)chf-solutions.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sunshine Heart, Inc. via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 23.05.2017 - 13:00 Uhr
Sprache: Deutsch
News-ID 544213
Anzahl Zeichen: 4580
contact information:
Town:
Minnesota
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 133 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sunshine Heart Announces Company Name Change to CHF Solutions, Inc. and New NASDAQ Ticker Symbol to Reflect New Commercial Focus"
steht unter der journalistisch-redaktionellen Verantwortung von
Sunshine Heart, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
